Skip to main content
Top
Published in: Acta Diabetologica 3/2012

01-06-2012 | Case Report

Choreoathetosis associated with non-chetotic hyperglycemia

Authors: Roberto Valenti, Elena Ceccarelli, Alfonso Cerase, Martina Ruvio, Cosimo Capodarca, Giuseppe Martini, Ranuccio Nuti

Published in: Acta Diabetologica | Issue 3/2012

Login to get access

Abstract

Choreoathetosis is a rare neurologic complication of the diabetic disease. The purpose of this case report is to increase the knowledge of such occurrence by describing the case of an elderly woman who was admitted to our institution for an over 20-day history of choreic movement in the left side of the body. She had a 6-year history of type 2 diabetes mellitus with a poor metabolic control including a glycosylated hemoglobin of 13%. Unenhanced computed tomography of the brain was negative. At magnetic resonance imaging, the right putamen showed high signal intensity on T1-weighted images and an area of high signal intensity on T2-weighted images, diffusion-weighted images and apparent diffusion coefficient maps. During the hospitalization, an adequate diet therapy was performed, and insulin therapy was gradually adjusted using regular insulin at main meals associated with basal insulin (glargine) “bed time”. This resulted in progressive normalization of blood glucose values and an improvement of dyskinesia. There is a deep correlation between non-chetotic hyperglycemia and neurologic lesions leading to choreoathetosis. The etiopathogenesis seems multifactorial, and include hyperosmolar damage on cortical cells, alteration in GABA neurotransmission and in cerebral vascular self-regulation mechanism. Notably, in DM type 2 choreoathetosis may be related to both vascular and neuro-metabolic alterations in the basal nucleus due to inadequate glycemic control continuing in the time. This rare complication of DM type 2 is a pathological entity to be considered benign, since it is generally transient and reversible with the attainment of an adequate metabolic compensation.
Literature
1.
go back to reference Crossman AR, Sambrook MA, Jackson A (1984) Experimental hemichorea/hemiballism in the monkey: studies on the intracerebral situ of action in a drug induced dyskinesia. Brain 107:579–596PubMedCrossRef Crossman AR, Sambrook MA, Jackson A (1984) Experimental hemichorea/hemiballism in the monkey: studies on the intracerebral situ of action in a drug induced dyskinesia. Brain 107:579–596PubMedCrossRef
2.
go back to reference Hamide A, Kumarsamy R, Srimannarayana J, Mathew J, Das AK (2002) Corea due to non-ketotic hyperglycemia. Neurol India 50(2):213–214PubMed Hamide A, Kumarsamy R, Srimannarayana J, Mathew J, Das AK (2002) Corea due to non-ketotic hyperglycemia. Neurol India 50(2):213–214PubMed
3.
go back to reference Branca D, Gervasio O, Le Piane E, Russo C, Aguglia U (2005) Chorea induced by non-ketotic hyperglycaemia: a case report. Neurol Sci 26:275–277PubMedCrossRef Branca D, Gervasio O, Le Piane E, Russo C, Aguglia U (2005) Chorea induced by non-ketotic hyperglycaemia: a case report. Neurol Sci 26:275–277PubMedCrossRef
4.
go back to reference Hsu JL, Wang HC (2004) Hyperglycemia-induced unilateral basal ganglion lesion with and without hemichorea. J Neurol 251:1486–1490PubMedCrossRef Hsu JL, Wang HC (2004) Hyperglycemia-induced unilateral basal ganglion lesion with and without hemichorea. J Neurol 251:1486–1490PubMedCrossRef
5.
go back to reference Shimonura T, Nozaki Y (1995) Hemichorea-Hemiballism associated with nonketotic hyperglycemia and presenting with unilateral hyperintensity of the putamen on MRI T1-weighted images-a case report. No To Shinkei 47:557–561 Shimonura T, Nozaki Y (1995) Hemichorea-Hemiballism associated with nonketotic hyperglycemia and presenting with unilateral hyperintensity of the putamen on MRI T1-weighted images-a case report. No To Shinkei 47:557–561
6.
go back to reference Iwataa A, Koikeb F, Arasakic K, Tamakic M (1999) Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes. J Neurol Sci 163:90–93CrossRef Iwataa A, Koikeb F, Arasakic K, Tamakic M (1999) Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes. J Neurol Sci 163:90–93CrossRef
7.
go back to reference Boderick JP, Hangen T, Brott T et al (1995) Hyperglycemia and haemorrhagic transformation on cerebral infarcts. Stroke 26:484–487CrossRef Boderick JP, Hangen T, Brott T et al (1995) Hyperglycemia and haemorrhagic transformation on cerebral infarcts. Stroke 26:484–487CrossRef
8.
go back to reference Ziemann U, Koc J (2000) Exploration of motor cortex excitability in a diabetic patient with hemiballism-hemicorea. Mov Disord 15(5):1000–1005PubMedCrossRef Ziemann U, Koc J (2000) Exploration of motor cortex excitability in a diabetic patient with hemiballism-hemicorea. Mov Disord 15(5):1000–1005PubMedCrossRef
9.
go back to reference Shen WC (2001) Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: report of seven new cases and a review of literature. J Neurol 248:750–755PubMedCrossRef Shen WC (2001) Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: report of seven new cases and a review of literature. J Neurol 248:750–755PubMedCrossRef
10.
go back to reference Ohara S, Nakagawa S, Tabata K, Hashimoto T (2001) Hemiballism with hyperglycemia and striatal T1-MRI hypintensity: an autopsy report. Mov Disord 16(3):521–525PubMedCrossRef Ohara S, Nakagawa S, Tabata K, Hashimoto T (2001) Hemiballism with hyperglycemia and striatal T1-MRI hypintensity: an autopsy report. Mov Disord 16(3):521–525PubMedCrossRef
11.
go back to reference Chu K, Kang D-W, Kim D-E, Park S-H, Roh J-K (2002) Diffusion-weighted and gradient echo magnetic resonance findings or hemichorea-hemiballismus associated with diabetic hyperglycemia: a hyperviscosity syndrome? Arch Neurol 59(3):448–452PubMedCrossRef Chu K, Kang D-W, Kim D-E, Park S-H, Roh J-K (2002) Diffusion-weighted and gradient echo magnetic resonance findings or hemichorea-hemiballismus associated with diabetic hyperglycemia: a hyperviscosity syndrome? Arch Neurol 59(3):448–452PubMedCrossRef
12.
go back to reference Abe K, Hasegawa H, Kobayashi Y, Fujimura H, Yorifuji S, Bitoh S (1990) A gemistocytic astrocytoma demonstrated high intensity on MR images: protein hydration layer. Neuroradiology 32:166–167PubMedCrossRef Abe K, Hasegawa H, Kobayashi Y, Fujimura H, Yorifuji S, Bitoh S (1990) A gemistocytic astrocytoma demonstrated high intensity on MR images: protein hydration layer. Neuroradiology 32:166–167PubMedCrossRef
13.
go back to reference Brunberg J, Chenevert T, McKeever P et al (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 16:361–371PubMed Brunberg J, Chenevert T, McKeever P et al (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 16:361–371PubMed
14.
go back to reference Battisti C, Forte F, Rubenni E, Dotti MT, Bartali A, Gennari P, Federico A, Cerase A (2009) Two cases of hemichorea-hemiballism with nonketotic hyperglycemia: a new point of view. Neurol Sci 30(3):179–183PubMedCrossRef Battisti C, Forte F, Rubenni E, Dotti MT, Bartali A, Gennari P, Federico A, Cerase A (2009) Two cases of hemichorea-hemiballism with nonketotic hyperglycemia: a new point of view. Neurol Sci 30(3):179–183PubMedCrossRef
Metadata
Title
Choreoathetosis associated with non-chetotic hyperglycemia
Authors
Roberto Valenti
Elena Ceccarelli
Alfonso Cerase
Martina Ruvio
Cosimo Capodarca
Giuseppe Martini
Ranuccio Nuti
Publication date
01-06-2012
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0185-5

Other articles of this Issue 3/2012

Acta Diabetologica 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine